| notes | unmstricted | restricted | total funds | total funds | ||||
|---|---|---|---|---|---|---|---|---|
| funds | funds | 2020 | 2019 | |||||
| 6 | 8 | 8 | 8 | |||||
| Income and endowments | ||||||||
| Donations and legacies |
47100 | 0 | 47100 | 80000 | ||||
| Total income | 47100 | 47100 | 80000 | |||||
| Expenditure | ||||||||
| Expenditure on charitable |
activities | 47119 | 47119 | 43839 | ||||
| Total expenditure | 47119 | 47119 | 43839 | |||||
| Net incomel(degcit) | -19 | -19 | 36161 | |||||
| Transfers between |
funds | 0 | 0 | |||||
| Net movement in |
funds | -19 | ||||||
| Reconciliation of |
funds | |||||||
| Total funds brought |
fonvard | 50664 | 50664 | 14503 | ||||
| Total funds carried forward | 50645 | 50645 | 50664 |
| 2020 | 2019 | ||||
|---|---|---|---|---|---|
| notes | 6 | ||||
| Fixed Assata | |||||
| 609 | 813 | ||||
| Current Assets | |||||
| Bank | 39021 | 45536 | |||
| Debtors and | prepayinents | 12215 | 5515 | ||
| 51236 | 51051 | ||||
| Current liabgities | |||||
| Creditors | 1200 | 1200 | |||
| 1200 | 1200 | ||||
| Net Current | assets | '50036 | 49851 | ||
| Net Assets | 50645 | 50664 | |||
| Funds ofthe charity | |||||
| Unrestricted | funds | 50645 | . 50664 | ||
| Restricted funds | 0 | 0 | |||
| Total funds | 50645 | 50664 |
| Statement ofCash Flows |
f | orthe year end | ed 31stDecember 2019 | ||
|---|---|---|---|---|---|
| 2020 | 2019 | ||||
| 8 | 8 | ||||
| Cash flows from operating | activities | ||||
| Net income | -19 | 36161 | |||
| Adjustments for. |
|||||
| Depreciation | 204 | 271 | |||
| Accrued income | 0 | 0 | |||
| Changes in: | |||||
| Debtors | -5700 | 10188 | |||
| Creditors | 0 | 0 | |||
| Net cash from operating activities |
-6515 | 46620 | |||
| Cash flows from investing | activities | ||||
| Purchase cftangible assets | 0 | 1084 | |||
| Net cash used in investing |
activities | 0 | 1084 | ||
| Net increase in cash and |
cash equivalents | -6515 | 45536 | ||
| Cash and cash equivalents | at beginning | ofyear | 45536 | 0 | |
| Cash and cash equivalents | at end ofyear | 39021 | 45536 |
| 2. Income | from | donations | and legacies | |||||
| unrestricted | restricted | total funds | ||||||
| funds 9 |
funds | 2020f | ||||||
| Donations | 0 | 0 | 0 | |||||
| Grants | ||||||||
| Colgate | 0 | 0 | ||||||
| GSK | 30000 | 30000 | ||||||
| KCL | 2100 | 2100 | ||||||
| Proctor and | Gamble | 0 | 0 | |||||
| Unilever | 15000 | 15000 | ||||||
| 7100 | 47100 | |||||||
| unmstricted | ~astrl etcd | total funds | ||||||
| funds 8 |
fundsf | 2019 6 |
||||||
| Donations | 0 | 0 | 0 | |||||
| Grants | ||||||||
| Colgate | 0 | 0 | ||||||
| GSK | 65000 | 65000 | ||||||
| Proctor and | Gamble | 0 | 0 | |||||
| Unilever | 15000 | 15000 | ||||||
| 80000 | 80000 | |||||||
| 3. Expenditure | on charitable | activities | ||||||
| unrestricted | restricted | total funds | ||||||
| funds | funds | 2020 | ||||||
| 6 | 9 | 6 | ||||||
| Charitable | activities | 25443 | 0 | 25443 | ||||
| Support costs | 20426 | 0 | 20426 | |||||
| Governance | costs | 1250 | 0 | 1250 | ||||
| 47119 | 47119 | |||||||
| unrestricted | restricted | total funds | ||||||
| funds 6 |
funds 6 |
2019f | ||||||
| Charitable | activities | 6362 | 0 | 6362 | ||||
| Support costs | 36277 | 0 | 36277 | |||||
| Governance | costs | 1200 | 0 | 1200 | ||||
| 43839 | 43839 |